Provectus Biopharmaceuticals (PVCT) Stock Chart & Stock Price History $0.11 0.00 (-2.58%) As of 02/21/2025 03:06 PM Eastern Add Compare Share Share Chart Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Provectus Biopharmaceuticals Stock Price Performance 5 Day Performance+1.44%1 Month Performance-6.86%3 Month Performance-10.63%6 Month Performance-3.64%Year-To-Date Performance-11.82%1 Year Performance-26.92% Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address PVCT Stock Chart for Saturday, February, 22, 2025 PVCT Chart by TradingView Provectus Biopharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$0.11$0.11-2.58%$0.11$0.1135,182 shs$44.51 million02/20/2025$0.11$0.11+0.93%$0.11$0.1176,308 shs$45.68 million02/19/2025$0.10$0.11+2.67%$0.11$0.1189,511 shs$45.26 million02/18/2025$0.10$0.10+0.48%$0.11$0.1096,750 shs$44.09 million02/17/2025$0.10$0.10$0.10$0.1060,560 shs$43.88 million02/14/2025$0.10$0.10+1.26%$0.10$0.1060,560 shs$43.88 million02/13/2025$0.10$0.10-0.48%$0.11$0.10133,413 shs$43.33 million02/12/2025$0.10$0.10+0.78%$0.11$0.10146,001 shs$43.54 million02/11/2025$0.10$0.10-1.63%$0.11$0.10153,405 shs$43.21 million02/10/2025$0.10$0.10+8.85%$0.10$0.08152,928 shs$43.92 million Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$0.10$0.10-0.83%$0.10$0.10268,903 shs$40.35 million02/06/2025$0.10$0.10-1.73%$0.10$0.10169,143 shs$40.68 million02/05/2025$0.10$0.10+0.51%$0.10$0.10128,970 shs$41.40 million02/04/2025$0.10$0.10-2.20%$0.10$0.10196,542 shs$41.19 million02/03/2025$0.11$0.10-5.11%$0.11$0.10337,860 shs$42.11 million01/31/2025$0.11$0.11-3.56%$0.11$0.11641,776 shs$44.38 million01/30/2025$0.11$0.11-3.18%$0.11$0.1197,150 shs$46.02 million01/29/2025$0.12$0.11-3.66%$0.11$0.117,000 shs$47.53 million01/28/2025$0.11$0.12+2.18%$0.12$0.1140,450 shs$49.34 million01/27/2025$0.12$0.11-1.29%$0.12$0.1151,195 shs$48.29 million01/24/2025$0.12$0.12-1.27%$0.12$0.11108,695 shs$48.92 million01/23/2025$0.11$0.12+3.69%$0.12$0.12551,929 shs$49.55 million01/22/2025$0.11$0.11+1.70%$0.12$0.11523,189 shs$47.79 million01/21/2025$0.11$0.11-2.19%$0.12$0.11454,705 shs$46.99 million Related Companies ADCT Stock Price Chart NKTX Stock Price Chart LCTX Stock Price Chart ENTA Stock Price Chart CKPT Stock Price Chart HURA Stock Price Chart STRO Stock Price Chart ACTU Stock Price Chart NVCT Stock Price Chart ADAP Stock Price Chart Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PVCT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
